Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

Tekijä Roy, V., LaPlant, B. R., Gross, G. G., Bane, C. L., Palmieri, F. M.
Julkaistu 2009

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Tekijä Inwards, D. J., Fishkin, P. A., LaPlant, B. R., Drake, M. T., Kurtin, P. J., Nikcevich, D. A., Wender, D. B., Lair, B. S., Witzig, T. E.
Julkaisussa Ann Oncol (2014)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Tekijä Inwards, D J, Fishkin, P A, LaPlant, B R, Drake, M T, Kurtin, P J, Nikcevich, D A, Wender, D B, Lair, B S, Witzig, T E
Julkaisussa Ann Oncol (2019)

Elevated Soluble IL-2Rα, IL-8, and MIP-1β Levels are Associated with Inferior Outcome and are Independent of MIPI Score in Patients with Mantle Cell Lymphoma

Tekijä Sonbol, M. B., Maurer, M. J., Stenson, M. J., Allmer, C., LaPlant, B. R., Weiner, G. J., Macon, W. R., Cerhan, J. R., Witzig, T. E., Gupta, M.
Julkaisussa Am J Hematol (2014)

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia

Tekijä Sfeir, J G, Drake, M T, LaPlant, B R, Maurer, M J, Link, B K, Berndt, T J, Shanafelt, T D, Cerhan, J R, Habermann, T M, Feldman, A L, Witzig, T
Julkaisussa Blood Cancer J (2017)

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Tekijä Witzig, T E, Reeder, C B, LaPlant, B R, Gupta, M, Johnston, P B, Micallef, I N, Porrata, L F, Ansell, S M, Colgan, J P, Jacobsen, E D, Ghobrial, I M, Habermann, T M
Julkaistu 2011

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Tekijä Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R. L., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, Giovannino, Habermann, T. M., Witzig, T. E., Vitolo, U., Nowakowski, G. S.
Julkaisussa Blood Cancer J (2018)